Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Angiotensin
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
alunacedase alfa
(APN01) / Apeiron Biologics
nesvacumab
(REGN910) / Regeneron
cysteamine-pantetheine disulfide
(TTI-0102) / Thiogenesis Therap
vanucizumab
(RG7221) / Roche
ION904
/ Ionis
ACE2 CAR-NK cells
/ Chongqing Sidemu Biotechnology Technology
BL-7040
/ Yissum Research Development Company, BioLineRx
CLR325
/ Novartis
GL1001
/ Ore Holdings
INV-144
/ InVasc Therap
NKG2D-ACE2 CAR-NK cells
/ Chongqing Sidemu Biotechnology Technology
rimteravimab
(XVR011) / ExeVir Bio